Username:  
Password:  
Focal Point Login
 Home  Meetings References Search for Events Search for Experts

View the event

Reference:3455
Country:Philippines
Multiple country event:No
Region:WPRO
City:Various
Start date:1 October 2010
End date:24 August 2011
Estimated duration:
Status:Completed - Complété
 (The mission has taken place)

Title:DRS Protocol Development
Type:Mission
Terms of Reference:- to conduct sample size calculation and sampling design
- to assisting NTRL in developing the DRS protocol, which covers the objectives of the survey, definition of "case", sample size, sampling design, culture and DST methods, training for health workers who are involved in DRS, informed consent, patient interviews, data and specimen collection, transportation and testing, data management and analysis, quality assurance of DRS, monitoring and supervision, DRS forms and ethical considerations
Training Opportunity:No
Website:
Purpose 1:MDR-TB / XDR-TB
Purpose 2:M&E/supervision/ impact measurement
Purpose 3: 
Other purpose:

Entered by:WHO/WPRO
Partner 1:
Partner 2:
Partner 3:
Contact name:Woojin Lew
Contact email:leww@wpro.who.int
Other agencies: 

Funding needs:No
Funding source:USG / TBTEAM
Other funding source:
Available funding:$ 20,000
Funding gap:$ 0
Global Fund reference: 

Comments:Dr. A Ohkado and Dr. N Yamada from the Research Institute of Tuberculosis (RIT), Japan, Dr. Jesus Sarol Jr. (Local consultant), the DRS Technical Working Group (TWG), as well as the WHO country office have been providing on-going technical assistance from October 2010 to the 24th of August 2011 when the DOH officially approved the 2nd DRS protocol. The external and local consultants (statistician and epidemiologist) focused on sample size calculation and sampling design. The TWG focused more on assisting NTRL in developing the DRS protocol, which covers the objectives of the survey, definition of "case", sample size, sampling design, culture and DST methods, training for health workers who are involved in DRS, informed consent, patient interviews, data and specimen collection, transportation and testing, data management and analysis, quality assurance of DRS, monitoring and supervision, DRS forms and ethical considerations. The complex protocol development, therefore, involved multiple people working on various aspects of the document. Actual patient enrolment for the DRS started in September 2011. The TWG will conduct monitoring and evaluation of the DRS implementation every 2 months to ensure the quality of survey. External consultants (RIT) will be involved again at the data management and analysis stage, and results of the 2nd DRS are expected to come out in late 2012.

This survey is fundamental to all Global Fund grants in the Philippines given the large MDR-TB component. Periodic data collection must be done (properly) in order to provide an evidence base for MDR-TB scale-up activities and, more generally, for the monitoring of recording and reporting practices at all levels (i.e. data verification).
 

There are no documents attached associated with this event.

There are no experts (roster) associated with this event.


Experts (non-roster) associated with this event

  Dr Woojin Lew leww@wpro.who.int    
  Dr A Okhado N/A    
  Dr Jesus Sarol Jr N/A    
  Dr N Yamada N/A    

Date Created: 9 May 2011
Entered By: WPRO




© World Health Organization 2013       Stop TB Partnership home page       Contact us